HOME >> BIOLOGY >> NEWS
Dinosaur symposium at the Smithsonian Institution

The Smithsonian's National Museum of Natural History will host "Dinosaurs in the New Millennium," the museum's first symposium on dinosaur science, Saturday and Sunday, Dec. 13-14. All events are free and open to the public and will be held in the Museum's Baird Auditorium. Scientists, dinosaur enthusiasts and families are all invited to attend.

The public symposium, organized and hosted by Smithsonian dinosaur curator Dr. Matthew Carrano, will present speakers from 11 universities and museums around the world. They will discuss a wide variety of topics in dinosaur science including dinosaur growth, diet and health, as well as the world in which they lived.

On Dec. 13, experts will discuss various aspects of dinosaur biology and present a roadmap for new theories and discoveries in the coming decades. Several of the 30-minute talks will be followed by a question-and-answer session. The lectures begin at 9 a.m. and continue until 4:45 p.m.

On Dec. 14, world-famous dinosaur paleontologist Jack Horner will kick off the second day of the symposium with the keynote speech at noon. Horner is the curator of paleontology at the Museum of the Rockies in Bozeman, MT. He is also a senior scholar at the Smithsonian Institution. His talk, "Dinosaur Science in the 21st Century," will be followed by a moderated roundtable discussion.

From 3-5 p.m., Smithsonian paleontologists will give a series of talks about "The World of Dinosaurs." These talks will cover topics ranging from the origin of flowers, ancient plants and flowers, prehistoric insects, and the extinction of dinosaurs.

Visitors may also enjoy the museum's Dinosaur Hall, eating at the Fossil Caf, or shopping at the TriceraShop, a special museum shop devoted to dinosaur-related toys, clothing, books and more.

The Smithsonian's National Museum of Natural History is located at 10th Street and Constitution Ave, N.W. in Washington, D.C. Museum hours are 10 a.m. -
'"/>

Contact: Michele Urie
urie.michele@nmnh.si.edu
202-786-2950
Smithsonian Tropical Research Institute
8-Dec-2003


Page: 1 2

Related biology news :

1. Dinosaur fossil record compiled, analyzed
2. Dinosaur, crab fossils reveal ecosystem secrets
3. Dinosaur ancestors vision possibly nocturnal
4. Dinosaur discoveries in Montana
5. Dinosaurs had a "rostral nostril," says Science researcher
6. Dinosaurs large noses may have been key to physiological processes
7. Dinosaurs: New study counters age-old theory
8. Dinosaur fossils reveal evolutions big picture, says Paul Sereno
9. Dinosaurs And Neanderthals
10. Fossil Footprints Show Foot-Movement Similarity In Dinosaurs And Birds
11. Montana Scientist Returns From Dinosaur Nesting Site In Patagonia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dinosaur symposium the Smithsonian Institution

(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... phosphatidylserine is a natural food supplement produced from ... and slow memory loss, it,s a popular treatment ... team headed by Prof. Gil Ast and Dr. ... Human Molecular Genetics have discovered that ... involved in degenerative brain disorders, including Parkinson,s disease ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
(Date:5/21/2013)... 2013 Custom Learning Designs, Inc.(CLD) ... solution using Tin Can API combined with its ... is a leading developer of training content and ... worldwide. , Tin Can API is a ... and trainers more accurately measure the Return on ...
(Date:5/21/2013)... ISTANBUL , May 21, 2013 ...  European Dialysis and Transplant Association) is the biggest congress ... renal replacement therapy. Nearly 10,000 participants are in ... discuss the latest research findings. New pioneering studies have ... al. "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: